Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
XEIA Venture Partners, formerly known as Focalpoint Partners, is a venture capital firm based in San Francisco, CA. Established to explore the emerging field of 'Human 3,' the firm focuses on advancing health, wellbeing, and performance through innovative technologies. XEIA's investment strategy encompasses a wide range of sectors, including life sciences, artificial intelligence, hardware, software, deep tech, and health tech.
The firm currently manages a portfolio of 22 companies and operates with a global investment approach. XEIA Venture Partners emphasizes cross-disciplinary exploration, aiming to invest in technologies that contribute to a new epoch of human flourishing. The firm has established itself as a key player in the venture capital landscape, particularly in the fields of neuroscience and advanced therapies.
XEIA Venture Partners invests in a diverse array of sectors, including life sciences, artificial intelligence, hardware, software, deep tech, and health tech. Their investment thesis centers around the concept of 'Human 3,' which refers to the era of exponential human flourishing. The firm targets startups at various stages, from seed to growth equity, and seeks to support innovations that often defy conventional categorization.
In evaluating potential investments, XEIA looks for technologies that enhance health, wellbeing, and performance. They prioritize cross-disciplinary innovations that integrate multiple fields, particularly in neuroscience, brain-computer interfaces, psychedelic-assisted therapy, and genetic medicine. The firm is committed to identifying and supporting startups that align with their vision of advancing human capabilities through technology.
XEIA Venture Partners has built a notable portfolio of 22 companies, focusing on innovative solutions in health and technology. Key portfolio companies include:
Brom Rector, CFA - Founding Partner. Brom has extensive experience in venture capital and has led numerous successful investments in the health tech sector.
Sam Rector - Partner. Sam brings a wealth of knowledge in technology and investment strategies, focusing on innovative health solutions.
Li-Huei Tsai, PhD - Scientific Advisor, Director of MIT's Aging Brain Initiative. Li-Huei is a leading expert in neuroscience and contributes significant expertise to the firm's investment decisions.
To pitch to XEIA Venture Partners, founders should visit their website at focalpointlp.com. It is recommended to include a concise overview of the startup, the technology being developed, and its relevance to health and performance. While specific response times are not disclosed, a well-prepared pitch can enhance the likelihood of engagement.
In April 2025, XEIA Venture Partners established Fund II, focusing on early-stage investments in health and technology sectors. This fund aims to further support startups that align with their 'Human 3' investment thesis.
Throughout 2024, XEIA added several notable companies to its portfolio, including TippingPoint, Aperture, and NeuroBionics, which focus on innovative solutions in brain health and genetic medicine.
In 2023, the firm invested in Tara Mind and Pepper Bio, both of which are making strides in psychedelic therapy and drug target identification, respectively.
What stages does XEIA Venture Partners invest in?
XEIA Venture Partners invests in startups at various stages, including seed, Series A, Series B, and growth equity.
What sectors does XEIA focus on?
The firm focuses on sectors such as life sciences, artificial intelligence, hardware, software, deep tech, and health tech.
How can I pitch my startup to XEIA?
Founders can submit their pitches through the firm's website at focalpointlp.com. It is advisable to include a clear overview of the technology and its potential impact on health and performance.
What makes XEIA different from other venture capital firms?
XEIA Venture Partners emphasizes cross-disciplinary innovation, investing in technologies that contribute to the 'Human 3' era, which focuses on enhancing health and wellbeing through advanced technologies.
What is the typical check size for investments?
Specific check sizes are not publicly disclosed, but XEIA invests across various stages, indicating a flexible approach to funding based on the startup's needs.
What kind of support does XEIA provide to portfolio companies?
XEIA offers strategic guidance, access to a network of industry experts, and support in navigating the complex landscape of health and technology innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.